SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 21.36-3.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jerome T. Richards who wrote (1228)10/29/1997 11:45:00 AM
From: Ambrym Man   of 1693
 
Thanks. You will notice that no one has argued with my figures.
I posted the figures on Monday, and coincidently the Wall Street
Journal had an article that day about the influenza outbreak in Hawaii
and that it is time to to have a shot.
The relevance to my post is that they mentioned the swine influenza
where there was a nationwide campaign to get people to get innoculated. The year was 1976. Evidently some people became ill
with a condition with a fancy name. The article went on to say that
some people can still remember that, and are hesitent to have the
shot. Evidently there is a risk group for influenza and of that group
"58% of the population over 65 and 30% of the population under 65 get
the shot." So my strawhorse number of 15% of the population that would seek an h-pylori test is probably way low. My 20% market share for Quidel is probably high. Remember it is thought that that 50% of the US population over 50 have h-pylori.
I just caught the tail end of a CNN bit on it Monday night. I had just
tuned to that channel and all I heard was "-and the ulcer is cured."

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext